Common Contracts
3 similar License Agreement contracts by Medisafe 1 Technologies Corp, Safecode Drug Technologies Corp.
BETWEEN MEDISAFE 1 TECHNOLOGIES CORP., AS LICENSOR AND SAFECODE DRUG TECHNOLOGIES CORP., AS Licensee Dated: November 15, 2012 LICENSE AGREEMENTLicense Agreement • May 1st, 2013 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • New York
This License Agreement, dated this 15 day of November, 2012 (the "License Agreement"), is by and between Medisafe 1 Technologies Corp., a Delaware corporation having its principal office at 5a Hataltan Street, Jerusalem 96926, Israel (hereinafter, the "Licensor”) and Safecode Drug Technologies Corp., a Delaware corporation having its principal office at 6 Meever HaMiltah Street, Jerusalem 97761, Israel (hereinafter, the "Licensee”). The Licensor and Licensee are sometimes referred to individually, as a "Party" and collectively, as the "Parties."
BETWEEN MEDISAFE 1 TECHNOLOGIES CORP., AS LICENSOR AND SAFECODE DRUG TECHNOLOGIES CORP., AS Licensee Dated: November 15, 2012 LICENSE AGREEMENTLicense Agreement • November 20th, 2012 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • New York
This License Agreement, dated this 15 day of November, 2012 (the "License Agreement"), is by and between Medisafe 1 Technologies Corp., a Delaware corporation having its principal office at 5a Hataltan Street, Jerusalem 96926, Israel (hereinafter, the "Licensor”) and Safecode Drug Technologies Corp., a Delaware corporation having its principal office at 6 Meever HaMiltah Street, Jerusalem 97761, Israel (hereinafter, the "Licensee”). The Licensor and Licensee are sometimes referred to individually, as a "Party" and collectively, as the "Parties."
BETWEEN MEDISAFE 1 TECHNOLOGIES CORP., AS LICENSOR AND SAFECODE DRUG TECHNOLOGIES CORP., AS Licensee Dated: November 15, 2012 LICENSE AGREEMENTLicense Agreement • November 20th, 2012 • Safecode Drug Technologies Corp. • Surgical & medical instruments & apparatus • New York
This License Agreement, dated this 15 day of November, 2012 (the "License Agreement"), is by and between Medisafe 1 Technologies Corp., a Delaware corporation having its principal office at 5a Hataltan Street, Jerusalem 96926, Israel (hereinafter, the "Licensor”) and Safecode Drug Technologies Corp., a Delaware corporation having its principal office at 6 Meever HaMiltah Street, Jerusalem 97761, Israel (hereinafter, the "Licensee”). The Licensor and Licensee are sometimes referred to individually, as a "Party" and collectively, as the "Parties."
